Vir Biotechnology (VIR) Q3 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.56
-1.28
-1
-0.72

Details

Expected EPS
-0.722875
Actual EPS
-0.8
Surprise EPS
-0.08
Surprise Percent
+10.67%

Description

Vir Biotechnology (VIR) has reported earnings of -0.8 per share for Q3 2025.

0 Comments

Share your thoughts